Position in UTHR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$463,805
-$30,740 QoQ
Shares Held
856
+2.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#586
of 870 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Independent Advisor Alliance holds $3,917,447 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
98,746 | $2,430,138 | |
| 2 | VTRS |
Viatris Inc
|
32,752 | $520,101 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
856 | $463,805 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
17,885 | $286,695 | |
| 5 | HLN |
Haleon plc
|
22,091 | $206,108 | |
| 6 | CRDL |
Cardiol Therapeutics Inc.
|
10,000 | $10,600 |
All Filings in UTHR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $463,805 | 856 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $494,545 | 834 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $405,879 | 833 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $337,882 | 806 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $229,304 | 798 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||